2009
DOI: 10.1002/jcb.22409
|View full text |Cite
|
Sign up to set email alerts
|

Protein alterations induced by long‐term agonist treatment of HEK293 cells expressing thyrotropin‐releasing hormone receptor and G11α protein

Abstract: This study aimed to determine whether sustained stimulation with thyrotropin-releasing hormone (TRH), a peptide with important physiological functions, can possibly affect expression of plasma membrane proteins in HEK293 cells expressing high levels of TRH receptor and G(11)alpha protein. Our previous experiments using silver-stained two-dimensional polyacrylamide gel electrophoretograms did not reveal any significant changes in an overall composition of membrane microdomain proteins after long-term treatment … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 37 publications
0
11
0
Order By: Relevance
“…Protein spots showing altered abundance levels were excised from the gel, in-gel digested with trypsin, and analyzed by MALDI-TOF MS/MS as described previously [16]. Peptide mass-fingerprinting and subsequent database searching revealed the identity of altered proteins as summarized in Table 1.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Protein spots showing altered abundance levels were excised from the gel, in-gel digested with trypsin, and analyzed by MALDI-TOF MS/MS as described previously [16]. Peptide mass-fingerprinting and subsequent database searching revealed the identity of altered proteins as summarized in Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Strips were equilibrated for 15 min in 4 ml of EQ buffer (50 mM Tris, pH 6.8, 6 M urea, 30% glycerol, 2% SDS) containing 1% DTT, followed by a second 15-min equilibration in EQ buffer containing 4% iodacetamide and separated in the second dimension on 10% SDS-polyacrylamide gels using the Hoefer apparatus. Gels were stained with the fluorescent dye SYPRO Ruby or colloidal Coomassie G-250 for MALDI-TOF MS/MS and spot density was quantitatively analyzed by PDQuest software (Bio-Rad, Hercules, CA, USA) as described previously [16]. Proteins with altered expression were identified using a 4800 Plus MALDI TOF/TOF Analyzer [16].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, we have previously found that the addition of 10 mM TRH to the HEK293 cell line stably expressing TRH-R1 and G 11 m protein does not lead to apoptosis, although the cells stop growing [38]. On the contrary, a prolonged incubation of these cells with TRH increased the Bcl-2/Bax ratio and elevated the level of some proteins with anti-apoptotic and protective effects.…”
Section: Discussionmentioning
confidence: 99%
“…TRH has also been demonstrated to exert trophic actions in lower motor neurons of the spinal cord (Van den Bergh et al, 1991), and pro-TRH gene expression has been shown to play a role in preventing neuronal apoptosis in the CNS. Furthermore, long-term stimulation of clonal human fibroblast cells (HEK293) cells with TRH can engender multiple antiapoptotic effects, such as a decrease in caspase 3 and increased expression of mitochondrial proteins thought to play a role in antiapoptotic activity (Drastichova et al, 2010). Many of the CNS effects of TRH are coordinated through the coherent modulation of neurotransmitters such as glutamate, dopamine, norepinephrine, serotonin, acetylcholine, and GABA (Malthe-Soressen et al, 1978; Yarbrough, 1979; Deng et al, 2006; Jantas et al, 2009).…”
Section: Introductionmentioning
confidence: 99%